AI assistant
PROTHENA CORP PUBLIC LTD CO — Director's Dealing 2021
Feb 17, 2021
32782_dirs_2021-02-17_43658460-d66c-49e5-b46d-ae25eef08868.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PROTHENA CORP PUBLIC LTD CO (PRTA)
CIK: 0001559053
Period of Report: 2021-02-12
Reporting Person: HENNEY CHRISTOPHER S (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-02-12 | Employee Stock Option (Right to Buy) | $34.04 | D | 15000 | Disposed | 2025-05-22 | Ordinary Shares (15000) | Direct |
| 2021-02-12 | Employee Stock Option (Right to Buy) | $22.85 | A | 9803 | Acquired | 2025-05-22 | Ordinary Shares (9803) | Direct |
| 2021-02-12 | Employee Stock Option (Right to Buy) | $42.50 | D | 15000 | Disposed | 2026-05-20 | Ordinary Shares (15000) | Direct |
| 2021-02-12 | Employee Stock Option (Right to Buy) | $22.85 | A | 8426 | Acquired | 2026-05-20 | Ordinary Shares (8426) | Direct |
| 2021-02-12 | Employee Stock Option (Right to Buy) | $56.23 | D | 12000 | Disposed | 2027-05-18 | Ordinary Shares (12000) | Direct |
| 2021-02-12 | Employee Stock Option (Right to Buy) | $22.85 | A | 6315 | Acquired | 2027-05-18 | Ordinary Shares (6315) | Direct |
Footnotes
F1: On February 12, 2021, the issuer canceled, pursuant to the issuer's option exchange program, an option for 15,000 of the issuer's ordinary shares granted to the reporting person on May 22, 2015. In exchange, the reporting person received a replacement option, for 9,803 ordinary shares, having an exercise price of $22.85 per ordinary share.
F2: The shares subject to the option will vest and become exercisable on the one year anniversary of the date of grant, subject to the reporting person's continued service with the issuer through such one year anniversary.
F3: On February 12, 2021, the issuer canceled, pursuant to the issuer's option exchange program, an option for 15,000 of the issuer's ordinary shares granted to the reporting person on May 20, 2016. In exchange, the reporting person received a replacement option, for 8,426 ordinary shares, having an exercise price of $22.85 per ordinary share.
F4: On February 12, 2021, the issuer canceled, pursuant to the issuer's option exchange program, an option for 12,000 of the issuer's ordinary shares granted to the reporting person on May 18, 2017. In exchange, the reporting person received a replacement option, for 6,315 ordinary shares, having an exercise price of $22.85 per ordinary share.